PYXS – pyxis oncology, inc. (US:NASDAQ)
Stock Stats
News
Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026
Pyxis Oncology (PYXS) was upgraded by Wall Street Zen from "sell" to
Pyxis Oncology (PYXS) was downgraded by Wall Street Zen from "hold" t
Pyxis Oncology (PYXS) was upgraded by Wall Street Zen from "sell" to
Pyxis Oncology (PYXS) had its price target lowered by Stifel Nicolaus from $9.00 to $8.00. They now have a "buy" rating on the stock.
Form 4 Pyxis Oncology, Inc. For: Mar 24 Filed by: Dupont Jakob
Form 4 Pyxis Oncology, Inc. For: Mar 24 Filed by: Wadhane Jitendra
Form 4 Pyxis Oncology, Inc. For: Mar 24 Filed by: FLAVIN JOHN L
Form 4 Pyxis Oncology, Inc. For: Mar 24 Filed by: Metzger Michael A
Form 4 Pyxis Oncology, Inc. For: Mar 24 Filed by: Lewis-Hall Freda C
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.